MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Country |
 USA |
IPO year |
2017 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
1.3 M |
Market Cap[1] |
$ 4.45 M |
EBITDA (LTM) |
$ -5.49 M |
P/E (LTM) |
- |
P/S (LTM) |
3.17 |
EPS (LTM) |
-9.18 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
Acer Therapeutics
ACER
|
- | 2.71 % | $ 14 M | Nasdaq Capital Market | USA |
 |
Agenus
AGEN
|
$ 3.27 | -1.8 % | $ 1.17 M | Nasdaq Capital Market | USA |
 |
Agios Pharmaceuticals
AGIO
|
$ 29.33 | -2.98 % | $ 1.7 B | Nasdaq Global Select Market,SPB | USA |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
Akebia Therapeutics
AKBA
|
$ 1.26 | -3.44 % | $ 324 M | Nasdaq Global Market | USA |
 |
Akari Therapeutics, Plc
AKTX
|
$ 0.24 | 1.1 % | $ 5.73 B | Nasdaq Capital Market |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Aldeyra Therapeutics
ALDX
|
$ 5.49 | 0.52 % | $ 330 M | Nasdaq Global Select Market | USA |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
Alector
ALEC
|
$ 2.26 | -7.2 % | $ 233 M | Nasdaq Global Select Market,SPB | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market |  France |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
Aligos Therapeutics
ALGS
|
$ 7.02 | -0.21 % | $ 451 M | Nasdaq Global Select Market | USA |
 |
Alkermes plc
ALKS
|
$ 29.32 | -2.61 % | $ 4.83 B | Nasdaq Global Select Market |  Irlanda |
 |
Allogene Therapeutics
ALLO
|
$ 2.57 | -7.73 % | $ 403 M | Nasdaq Global Select Market,SPB | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
$ 330.95 | -0.59 % | $ 43.4 B | Nasdaq Global Select Market,SPB | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market | Britain |
 |
Altimmune
ALT
|
$ 4.2 | -2.55 % | $ 298 M | Nasdaq Global Market | USA |
 |
ALX Oncology Holdings
ALXO
|
$ 2.11 | 0.09 % | $ 110 M | Nasdaq Global Select Market,SPB | USA |
 |
Amgen
AMGN
|
$ 387.85 | 0.03 % | $ 209 B | Nasdaq Global Select Market,SPB | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
$ 20.22 | -0.05 % | $ 945 M | Nasdaq Global Select Market | USA |
 |
Amarin Corporation plc
AMRN
|
$ 13.62 | -1.3 % | $ 5.55 B | Nasdaq Global Market | Irlanda |
 |
AIM ImmunoTech
AIM
|
$ 0.92 | 5.25 % | $ 44.2 M | NYSE American | USA |
 |
AnaptysBio
ANAB
|
$ 54.61 | -0.8 % | $ 1.55 B | Nasdaq Global Select Market,SPB | USA |
 |
Anika Therapeutics
ANIK
|
$ 14.44 | 0.53 % | $ 212 M | Nasdaq Global Select Market,SPB | USA |
 |
ANI Pharmaceuticals
ANIP
|
$ 75.31 | 1.91 % | $ 1.45 B | Nasdaq Global Market,SPB | USA |
 |
Annexon
ANNX
|
$ 5.38 | -3.93 % | $ 739 M | Nasdaq Global Select Market | USA |
 |
Annovis Bio
ANVS
|
$ 2.6 | -2.99 % | $ 23.5 M | NYSE American | USA |
 |
ARCA biopharma
ABIO
|
- | 1052.0 % | $ 415 M | Nasdaq Capital Market | USA |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Acasti Pharma
ACST
|
- | 4.01 % | $ 150 M | Nasdaq Capital Market |  Canada |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Apellis Pharmaceuticals
APLS
|
$ 20.53 | -2.05 % | $ 2.59 B | Nasdaq Global Select Market,SPB | USA |
 |
Aptorum Group Limited
APM
|
$ 0.78 | -0.67 % | $ 4.25 M | Nasdaq Global Select Market | China |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Aprea Therapeutics
APRE
|
$ 0.88 | -3.71 % | $ 3.18 M | Nasdaq Global Select Market,SPB | USA |
 |
Aptevo Therapeutics
APVO
|
$ 7.28 | -0.55 % | $ 2.01 M | Nasdaq Capital Market | USA |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
 |
Aquestive Therapeutics
AQST
|
$ 3.99 | -0.15 % | $ 346 M | Nasdaq Global Market | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
$ 8.11 | -1.44 % | $ 219 M | Nasdaq Global Market,SPB |  Israel |
 |
Ardelyx
ARDX
|
$ 6.32 | -3.54 % | $ 1.52 B | Nasdaq Global Market | USA |
 |
Aileron Therapeutics
ALRN
|
- | 10.36 % | $ 9.8 M | Nasdaq Global Select Market | USA |
 |
argenx SE
ARGX
|
$ 762.51 | -0.58 % | $ 25 B | Nasdaq Global Select Market |  Niderland |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.